Audio Interview: What the U.S. Response to Covid-19 Looks Like Today

N Engl J Med. 2020 Nov 5;383(19):e123. doi: 10.1056/NEJMe2032843.
No abstract available

Publication types

  • Editorial
  • Interview

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Asymptomatic Diseases
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • COVID-19 Testing
  • COVID-19 Vaccines
  • Clinical Laboratory Techniques* / methods
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / drug therapy
  • Coronavirus Infections* / prevention & control
  • Coronavirus Infections* / transmission
  • Dexamethasone / therapeutic use
  • Disease Transmission, Infectious / prevention & control
  • Drug Development
  • Humans
  • Pandemics / prevention & control*
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / drug therapy
  • Pneumonia, Viral* / prevention & control
  • Pneumonia, Viral* / transmission
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / immunology
  • Treatment Outcome
  • Viral Vaccines*

Substances

  • Antibodies, Monoclonal
  • Antiviral Agents
  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • Viral Vaccines
  • spike protein, SARS-CoV-2
  • remdesivir
  • Adenosine Monophosphate
  • Dexamethasone
  • Alanine